UNITED STATES CELLULAR CORPORATION vs Anterix Inc. · latest fiscal year · computed from SEC XBRL filings
| Metric | AD | ATEX |
|---|---|---|
| Revenue | $163.0M | $6.5M |
| Revenue growth (YoY) | -95.6% | 7.8% |
| Operating margin | -56.8% | 1444.9% |
| Net margin | 29.9% | 1394.2% |
| FCF margin | 106.6% | 84.3% |
| Capex % of revenue | 16.7% | 0.5% |
Want AD against its full peer set, not just ATEX?
The CompsDesk pack: up to 12 peers you choose, up to 14 metrics (6 core guaranteed), trends for every filed year (up to five), a citation on every number — board-ready PDF + CSV, $249.
Green = better on that metric where direction is unambiguous. Source: SEC EDGAR XBRL (10-K). "n/a" = not disclosed under mapped tags; never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.